These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8216687)
1. Antibody feedback regulation in MRL/lpr mice. Heyman B; Gustavsson S; Kusakari C; Nose M; Kinoshita T; Klareskog L; Tarkowski A J Autoimmun; 1993 Aug; 6(4):437-48. PubMed ID: 8216687 [TBL] [Abstract][Full Text] [Related]
2. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655 [TBL] [Abstract][Full Text] [Related]
3. Abnormal behavior of gamma-committed B lymphocytes probed by a lymphocyte blastogenesis inhibitory factor in autoimmune MRL mice. Sugimura K; Wada Y; Kimura T; Ohno T; Kobayashi S; Azuma I Eur J Immunol; 1990 Sep; 20(9):1899-904. PubMed ID: 2209696 [TBL] [Abstract][Full Text] [Related]
4. Defective antigen-receptor-mediated regulation of immunoglobulin production in B cells from autoimmune strains of mice. Anderson CC; Cairns E; Rudofsky UH; Sinclair NR Cell Immunol; 1995 Aug; 164(1):141-9. PubMed ID: 7634346 [TBL] [Abstract][Full Text] [Related]
5. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease. Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819 [TBL] [Abstract][Full Text] [Related]
6. Suppressor T-cell activity in MRL/Mp-lpr/lpr mice: differential effects on primary and memory antibody responses of MRL/Mp-lpr/lpr and MRL/Mp-+/+ spleen cells to thymus dependent and thymus independent antigens in vitro. Wilson DA Cell Immunol; 1985 Dec; 96(2):312-26. PubMed ID: 2943418 [TBL] [Abstract][Full Text] [Related]
7. Follicular dendritic cell dysfunction and disorganization of lymphoid structures in MRL/lpr mice. Masuda A; Kasajima T Lab Invest; 1999 Jul; 79(7):849-57. PubMed ID: 10418825 [TBL] [Abstract][Full Text] [Related]
8. Unique surface phenotype of T cells in lymphoproliferative autoimmune MRL/Mp-lpr/lpr mice. Takei F J Immunol; 1984 Oct; 133(4):1951-4. PubMed ID: 6332141 [TBL] [Abstract][Full Text] [Related]
9. Comparison of antigen-specific T cell responses in autoimmune MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice. Scott CF; Tsurufuji M; Lu CY; Finberg R; Sy MS J Immunol; 1984 Feb; 132(2):633-9. PubMed ID: 6197469 [TBL] [Abstract][Full Text] [Related]
10. Suppression of antigen-specific interleukin 2 production in the MRL/MpJ-lpr/lpr mouse. Naides SJ J Immunol; 1986 Jun; 136(11):4113-21. PubMed ID: 2422273 [TBL] [Abstract][Full Text] [Related]
11. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
12. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128 [TBL] [Abstract][Full Text] [Related]
13. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253 [TBL] [Abstract][Full Text] [Related]
14. Nephritogenicity of the lprcg gene on the MRL background. Kimura M; Ogata Y; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A Immunology; 1992 Jul; 76(3):498-504. PubMed ID: 1526655 [TBL] [Abstract][Full Text] [Related]
16. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009 [TBL] [Abstract][Full Text] [Related]
17. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells. Tago F; Tsukimoto M; Nakatsukasa H; Kojima S Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952 [TBL] [Abstract][Full Text] [Related]
18. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261 [TBL] [Abstract][Full Text] [Related]
19. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice]. Kobayashi K; Hamano T; Kakishita E Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824 [TBL] [Abstract][Full Text] [Related]